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Abstract
Endometriosis is an inflammatory disease depending on estradiol, with TNF-α
being one of the most representative cytokines involved in its pathogenesis.
TNF-α acts through its bond to the TNFRp55 and TNFRp75 membrane
receptors. The aim of the present study was to analyze the effect of the
TNFRp55 deficiency on the development of ectopic endometriotic-like lesions.
Endometriosis was induced surgically in mice of the C57BL/6 strain, wild type
(WT) and TNFRp55-/- (KO). After four weeks, the peritoneal fluid was collected
and the lesions were counted, measured with a caliper, removed, weighed,
fixed or kept at -80°C. We evaluated the cell proliferation by proliferating cell
nuclear antigen (PCNA) immunohistochemistry and apoptosis by TUNEL
technique in the ectopic lesions. MMP-2 and MMP-9 activities (factors involved
in invasiveness) were measured by zymography in the peritoneal fluid; estradiol
and progesterone levels were measured by radioimmunoassay in the lesions
and in the peritoneal fluid. We found that in KO animals the mean number of
lesions established per mouse, the lesion volume, weight and cell proliferation
increased and apoptosis decreased. In addition, the activity of MMP-2 and the
estradiol level increased, whereas the progesterone level was not significantly
modified. In conclusion, the deficiency of TNFRp55 promoted the establishment
and development of endometriosis through an increase in the lesion size and
high levels of estradiol which correlate with an increase in the MMP-2 activity.
This is evidence of the possible association of the deregulation of the TNFRp55
expression and the survival of the endometriotic tissue in ectopic sites.
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Endometriosis is an inflammatory disease depending on estradiol, with TNF-α being one of 26 
the most representative cytokines involved in its pathogenesis. TNF-α acts through its bond to 27 
the TNFRp55 and TNFRp75 membrane receptors. The aim of the present study was to 28 
analyze the effect of the TNFRp55 deficiency on the development of ectopic endometriotic-29 
like lesions. Endometriosis was induced surgically in mice of the C57BL/6 strain, wild type 30 
(WT) and TNFRp55-/- (KO). After four weeks, the peritoneal fluid was collected and the 31 
lesions were counted, measured with a caliper, removed, weighed, fixed or kept at -80°C. We 32 
evaluated the cell proliferation by proliferating cell nuclear antigen (PCNA) 33 
immunohistochemistry and apoptosis by TUNEL technique in the ectopic lesions. MMP-2 34 
and MMP-9 activities (factors involved in invasiveness) were measured by zymography in the 35 
peritoneal fluid; estradiol and progesterone levels were measured by radioimmunoassay in the 36 
lesions and in the peritoneal fluid. We found that in KO animals the mean number of lesions 37 
established per mouse, the lesion volume, weight and cell proliferation increased and 38 
apoptosis decreased. In addition, the activity of MMP-2 and the estradiol level increased, 39 
whereas the progesterone level was not significantly modified. In conclusion, the deficiency 40 
of TNFRp55 promoted the establishment and development of endometriosis through an 41 
increase in the lesion size and high levels of estradiol which correlate with an increase in the 42 
MMP-2 activity. This is evidence of the possible association of the deregulation of the 43 









Endometriosis is a chronic disease, depending on estrogens, that affects women at 50 
reproductive age, causing inflammation, intense pelvic pain and reduced fertility. It is 51 
characterized by the implantation and growth of endometrial tissue outside the uterine cavity 52 
(Greene et al. 2016). Sampson´s theory, which states that epithelial and stromal cells reach the 53 
peritoneal cavity through late menstruation through the fallopian tubes and are then spread 54 
and implanted in the peritoneal cavity, is the mostly accepted mechanism to explain its 55 
etiology (Sampson 1927). However, this theory does not explain why more than 90% of 56 
women with late menstrual bleeding do not develop endometriosis, which suggests that there 57 
are genetic, immunological and/or biochemical factors which contribute to the development 58 
of the disease (Ahn et al. 2015). A significant component in the pathogenesis of 59 
endometriosis is the loss of normal patterns of communication between the endocrine and 60 
immune systems. It is known that the endometrial cells show reduced their capacity of death 61 
by apoptosis and increased their invasive capacity associated to hormonal alterations. These 62 
changes promote the resistance of the endometrial cells to the normal cleaning of the 63 
peritoneum by the immune system, responsible for the regulation of tissue homeostasis 64 
(Kitawaki et al. 2002, Antsiferova & Sotnikova 2012). 65 
Tumour necrosis factor-alpha (TNF-α), has an important function in the physiology of the 66 
proliferation and desquamation of the endometrium during the menstrual cycle. In addition, it 67 
plays a crucial role in inflammation, angiogenesis, cell proliferation and cell death. TNF-α 68 
acts on the target cells via two receptors: TNFRp55 (type 1) and TNFRp75 (type 2). 69 
TNFRp55 is characterized by a death domain in its intracellular region, whereas type 2 70 
receptor lacks such domain. Thus, the activation of TNFRp55 leads primarily to pro-71 
inflammatory and programmed cell death pathways (Rojas-Cartagena et al. 2005). In 72 
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endometriosis, there is evidence that indicate an aberrant function of the TNF system. For 73 
example, the levels of TNFRp55 expression in the endometrium of women with 74 
endometriosis during the late secretory phase, stage related to the apoptosis, were lower in 75 
relation to the endometrium without endometriosis, in coincidence with the almost absent 76 
apoptosis in the eutopic and ectopic endometrium (Boric et al. 2013). In addition, in a recent 77 
study that examined the serum levels of the soluble forms of both TNFRp55 and TNFRp75, 78 
has been found that the first is significantly higher in serum of endometriosis patients than 79 
controls and given that these soluble forms can modulate the effects of TNF by acting as 80 
antagonists (Othman et al. 2016), this may also be involved in the altered cell death observed 81 
in this pathology.   82 
On the other hand, the metalloproteinases (MMPs) are essential factors in the processes of 83 
invasiveness and tissue remodeling, which are secreted as latent pro-enzymes and activated by 84 
proteolytic cleavage (Di Carlo et al. 2009). Gelatin is an important protein of the extracellular 85 
matrix and it is sensitive to a high range of tissue proteinases, including MMP-2 and MMP-9 86 
gelatinases (Jana et al. 2016, Pan et al. 2016). These enzymes participate in the physiological 87 
cyclic changes of the endometrium, and several studies have shown that their steroid 88 
regulation is critical for the formation of the fragments of the endometrial tissue in ectopic 89 
sites (Bruner et al. 1997, Pitsos et al. 2009). In relation to this, there exists a correlation 90 
between the levels of MMP-2 and estradiol in the peritoneal fluid of patients with 91 
endometriosis (Huang et al. 2004).  92 
In turn, steroid hormones play an important role in the development of this pathology. 93 
Endometriosis seems to be associated to a decrease in the response capacity of the 94 
endometrial stromal cells to progesterone, which may be due to a decrease in the expression 95 
of the progesterone receptors (PR). A recent study demonstrates that inflammatory cytokines 96 
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like TNFα reduce the expression of PR. Thus, this effect may contribute to the progesterone 97 
resistance of women with endometriosis, which in turn is associated with hyperactive action 98 
of estradiol (Bulun et al. 2006, Li et al. 2016, Grandi et al. 2016). The proinflammatory and 99 
antiapoptotic effects of estradiol in endometrial cells appear to be exacerbated in women with 100 
endometriosis ( Reis et al. 2013).  101 
In view of all the above, the aim of the present study was to analyze the effect of the 102 
TNFRp55 deficiency on the establishment and growth of endometriotic-like lesions in an 103 
induced endometriosis model in mouse. In addition, we evaluated cell proliferation and 104 
apoptosis of endometriotic cells as well as factors related to invasiveness and endocrine 105 
status.  106 
 107 
Materials and methods 108 
Animals 109 
Female mice of the C57BL/6 strain, wild type (WT) and TNFRp55-/-
 
(KO) of two months, 110 
weighing 19-21 g were used. The TNFRp55-/-
 
mice were obtained from the Max von 111 
Pettenkofer Institute, Munich, Germany. Breeding colonies were established at the Animal 112 
Facility of the National University of San Luis (San Luis, Argentina) under rigorous light 113 
conditions (12 h light, 07:00-19:00, and 12 h darkness), controlled temperature (22±2ºC), with 114 
ad libitum water and sterile food. The experiments were carried out according to the rules for 115 
the care and use of laboratory animals of the National Institutes of Health (NIH, USA) and the 116 
Comité Institucional de Cuidado y Uso de Animales de Experimentación (CICUA) of the 117 
National University of San Luis, Argentina.  118 
 119 
 120 
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Surgical induction of endometriosis  121 
The endometriotic-like lesions were induced experimentally, as reported previously (Bilotas 122 
et al. 2010). The animals were anaesthetized via intraperitoneal with 100mg/kg of ketamine 123 
(Holliday Scott, Buenos Aires, Argentina) and 10 mg/kg of xylazine (Richmond, Buenos 124 
Aires, Argentina), and a mid-ventral incision was made to expose the bowels. The right 125 
uterine horn is removed from the animal, placed in DMEM-F12 (Gibco, USA) and divided 126 
longitudinally. It is later cut in three square pieces of approximately 4mm
2
 which are sutured 127 
to the intestine mesentery with only one stitch (supralong 6-0, Ethicon, NJ, USA). The area is 128 
hydrated with sterile physiological solution supplemented with antibiotic-antimycotic before 129 
closing the abdominal wall with the same suture material, with continuous stitches. The mice 130 
are monitored daily in relation to body weight, food consumption, preening behavior and 131 
activity. The mice were sacrificed by cervix dislocation after four weeks. Then, a small 132 
medioventral hole was opened through which 1.5 ml of PBS was injected in the peritoneal 133 
cavity of each animal, and the peritoneal fluid was collected and centrifuged at 10.000 g for 1 134 
minute. The supernatant was separated from the precipitate and kept at -80°C until the 135 
corresponding determinations. After that, the abdomen was completely opened to have access 136 
to the endometriotic-like lesions.  137 
 138 
Evaluation of the ectopic uterine tissue 139 
The lesions were identified, counted and measured with caliper in two perpendicular 140 
diameters. The volume of the developed lesions was calculated with the following equation: 141 
V=(4/3) π r1
2 
r2 (r1 and r2 are the radiuses and r1<r2). The lesions were removed, weighed and 142 
kept in as follows: one lesion per animal was fixed in buffer formaldehyde at 4% for 24h at 143 
4°C. The fixed specimens are embedded in paraffin, cut in 5µm sections and stained with 144 
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hematoxylin-eosin in order to examine microscopically the presence of histological identity 145 
signals of endometriosis (glands and stroma), or prepared for immunohistochemical technique 146 
and/or TUNEL. The remaining lesions were kept at -80°C for the rest of the determinations.  147 
 148 
Immunohistochemistry 149 
Proliferating cell nuclear antigen (PCNA), also called cyclin, is a 36-KD auxiliary protein of 150 
DNA polymerase-delta that has been found to be a useful marker in immunocytochemical 151 
studies of cell proliferation because its expression correlates with the proliferative state of the 152 
cell (Bravo et al. 1987). All sections were deparaffinized in xylene and rehydrated through 153 
graded alcohols. Endogenous peroxidase was blocked by treatment with 3% H2O2 for 30 min, 154 
followed by microwaving in 0.01M sodium citrate buffer for antigen retrieval. All the sections 155 
were then blocked with 4% BSA in PBS for 2h at room temperature and incubated overnight 156 
at 4°C with the anti-mouse PCNA rabbit polyclonal antibody (1:200, FL-261, Santa Cruz 157 
Biotechnology Inc., Santa Cruz, CA, USA) in PBS with 1% BSA at room temperature. After 158 
that, sections were incubated for 1h at room temperature with 1:200 goat biotinylated anti-159 
rabbit IgG antibody (Sigma-Aldrich, St Louis, MO, USA) followed by incubation with a 160 
streptavidin-peroxidise conjugate (VectorLabs, Burlingame, CA, USA) for 30 min at room 161 
temperature. The signal was developed with diaminobenzidine (DAB) as substrate (Cell 162 
Marque, CA, USA), and finally, the sections were counterstaining with Gill´s hematoxylin, 163 
dehydrated through grades alcohols, clarified in xylene, and properly mounted. As a negative 164 
control, one section of each slide was assayed without the primary antibody. PCNA positive 165 
cells were identified by the presence of brown nuclear reactivity. The percentage of PCNA 166 
positive cells was established using a standard light microscope at 400X. Quantification of 167 
cell proliferation was performed by counting a minimum of 100-150 randomly selected 168 
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epithelial and stromal cells per field and independently of the number of cells, 4-6 random 169 
fields per section were counted. The percentage of proliferating cells was calculated on the 170 
total and these percentages were then used to obtain the mean of each experimental group. 171 
 172 
TUNEL assay 173 
Fragmented DNA of apoptotic cells was detected using In Situ Cell Death Detection Kit POD 174 
TUNEL assay (Cat N° 11684817910 Roche, Basel, Switzerland), according to the 175 
manufacturer’s instructions. The detection was achieved using the peroxidase substrate, 176 
hydrogen peroxide, and the stable chromogen DAB. Using this procedure, apoptotic nuclei 177 
are stained dark brown. Finally, sections were counterstained with hematoxylin, mounted and 178 
analyzed in a light microscope. The number of apoptotic nuclei relative to total cells was 179 
determined by counting 150 randomly selected epithelial and stromal cells per field and 5 180 
random fields per section were counted. The percentage of apoptotic cells was calculated on 181 
the total and these percentages were then used to obtain the mean of each experimental group. 182 
 183 
Gelatin Zymography 184 
MMP-2 and MMP-9 enzymatic activity was determined by SDS-PAGE gelatin zymography. 185 
The samples, normalized in the same quantity of proteins, were mixed with the same volume 186 
of the sample buffer (0.3 M Tris-HCl pH 6.8, 2% SDS, 40% glycerol and 0.1% Bromophenol 187 
blue) and incubated for approximately 30 minutes at 37°C. Then they were subjected to 188 
electrophoresis in polyacrylamide gels at 10% (SDS-PAGE) containing 0.2% of gelatin 189 
(Merck, USA), under non reducing denaturalizing conditions at 4°C. Once electrophoresis 190 
was finished, the gels were washed with 2.5% of TritonX-100 (v/v) in buffer TNC (50 mM 191 
Tris-HCl pH 7.5, 0.5 M NaCl, 10 mM CaCl2 and 0.02% NaN3), twice for 15 minutes to 192 
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remove the SDS and thus allow the proteinases to recover their activity. After washing, the 193 
gels were incubated in TNC buffer with 1% TritónX-100 for 24 h at 37°C. Finally, the 194 
coloration with a 0.5% of Coomassie brilliant blue R-250 solution was carried out with the 195 
subsequent decoloration. The MMPs activity was evaluated observing the lysis zones. The 196 
bands intensity was determined by densitometry using ImageJ software and was expressed in 197 
arbitrary units.   198 
 199 
Radioimmunoassay (RIA) 200 
Samples of peritoneal fluid supernatant and homogenates of endometriotic lesions were used 201 
to measure progesterone and estradiol levels using a RIA kit (Beckman Coulter and 202 
DIAsource, respectively, DiagnosMed SRL, Buenos Aires, Argentina) following the 203 
manufacturer's instructions. The assays sensitivity was 0.05ng progesterone/ml and < 2.7pg 204 
estradiol/ml. The inter- and intra-assay coefficients of variation in all the assays were <10.0%. 205 
 206 
Western blot 207 
Protein extracts were obtained using TRIzol reagent and following the manufacturer’s 208 
indications (Invitrogen Life Technologies, Buenos Aires, Argentina). Protein concentration 209 
was determined by Lowry method. Aliquots containing 40µg of total protein were subjected 210 
to electrophoresis in 10% SDS-PAGE gels and then electrotransferred to PVDF membrane 211 
(Millipore Corporation, Bedford, MA, USA) at 100V for 1h in a transfer buffer (25mM Tris, 212 
192mM glycine and 20% v/v methanol, pH 8.3). The membrane was immersed in 5% non-fat 213 
milk in a PBST solution [KH2PO4 0.015M, NaH2PO4 0.017M, KCl 0.076M, NaCl 0.14M (pH 214 
7.4), 0.5% Tween-20] for 1h at room temperature, followed by an overnight incubation at 4°C 215 
with either rabbit anti-P450aromatase (SC-30086) or goat anti β-actin (SC-1615, Santa Cruz 216 
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Biotechnology Inc, CA, USA), 1:1000 dilution in 1% solution of non-fat powdered milk in 217 
PBST. After incubation with primary antibody, membranes were washed in PBST and 218 
incubated with donkey anti-goat IgG peroxidase-linked antibody (Cat sc-2020, Santa Cruz 219 
Biotechnology Inc, CA, USA) 1:5000 dilution in 1% milk for 1h at room temperature and 220 
goat anti-rabbit IgG peroxidase-linked antibody (Cat: sc-2004, Santa Cruz Biotechnology Inc, 221 
CA, USA) 1:5000 dilution in 1% milk for 3h at room temperature, respectively. Following 222 
washing in PBST, blots were developed using an enhanced chemiluminescence Western 223 
blotting detection system Thermo Scientific Super signal West Pico chemiluminescence 224 
(Pierce Biotechnology, Rockford, IL, USA) and exposed to X-ray films Thermo Scientific 225 
CL-XPosureTM Film (Pierce Biotechnology, Rockford, IL, USA). The mean of intensity of 226 
each band was measured using the NIH ImageJ software (Image Processing and Analysis in 227 
Java fromhttp://rsb.info.nih.gov/ij/). P450aromatase (P450arom) protein levels were 228 
normalized against β-actin (endogenous control).  229 
 230 
RNA isolation and RT-PCR analysis 231 
Total RNA was isolated from endometriotic lesions using TRIzol Reagent (Invitrogen Life 232 
Technologies, Buenos Aires, Argentina), according to the manufacturer’s instructions. 233 
Purified total RNAs were then quantified and assessed for purity by measurement of the 234 
260/280 ratio using an UV spectrophotometer Beckman DU-640 B (CA, USA). Only samples 235 
with 260/280 ratio of 1.8 to 2.0 were used. The integrity was confirmed by running 2µg RNA 236 
on a 0.8 % agarose gel. After GelRed™ (Biotium, Hayward, CA, USA) staining RNA bands 237 
were visualized with a UV transilluminator and 28S and 18S rRNA band patterns were 238 
analyzed. Two micrograms of total RNA were reverse transcribed at 37°C using random 239 
primers and M-MLV Reverse Transcriptase (Promega Inc., Buenos Aires, Argentina) in a 240 
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26µl reaction mixture. For amplification of the reverse transcription (RT) products, the 241 
reaction mixture consisted of 1× Green Go Taq reaction buffer, 0.2mM deoxynucleoside 242 
triphosphates, 0.5µM specific oligonucleotide primers and 1.25U Go Taq DNA polymerase 243 
(Promega Inc. Buenos Aires, Argentina) in a final volume of 50µl. The PCR primers were 244 
designed using Primer Express 3.0 software (Applied Biosystems, USA). The primers 245 
information is shown in Table 1. The amplification of the cDNA was performed using a 246 
thermalcycler (My Cycler, BioRad, Buenos Aires, Argentina). Reaction products were 247 
electrophoresed on 2% agarose gels, visualized with GelRed, and examined by ultraviolet 248 
transillumination. Band intensities of RT-PCR products were quantified using ImageJ (Image 249 
Processing and Analysis in Java from http://rsb.info.nih.gov/ij/). Relative levels of mRNA 250 
were expressed as the ratio of signal intensity for the target genes relative to that for the 251 
housekeeping gene β-actin. 252 
 253 
Statistical analysis 254 
Statistical analysis was performed using GraphPad Prism (Version 5, GraphPad Software Inc. 255 
San Diego SA).Values are presented as the mean ± SEM. Differences between the means of 256 
each group were analyzed using the Student´s t-test. Pearson’s correlation coefficient was 257 
used to evaluate the relationship between estradiol levels and MMP-2 activity in peritoneal 258 










Effect of the TNFRp55 deficiency on the endometriotic-like lesions establishment and 266 
growth  267 
The macroscopic evaluation of the ectopic uterine tissue revealed that the number of 268 
established lesions increased in animals with receptor deficiency (P<0.05) (Fig. 1A). In 269 
addition, we observed that the lesions volume and weight were higher in KO animals than in 270 
WT animals (P<0.05 and P<0.001, respectively) (Fig. 1B and C). These results show the 271 
relevance of TNFRp55 in the development of the ectopic endometrial tissue. 272 
 273 
Effect of the TNFRp55 deficiency on the cell proliferation and apoptosis in 274 
endometriotic-like lesions  275 
The TNFRp55 deficiency caused an increase in the percentage of cell proliferation (P<0.01) 276 
(Fig. 2A) and a decrease in the percentage of apoptosis cells (P<0.001) (Fig. 2B). There were 277 
no significant differences between epithelial and stromal cell. These results suggest that the 278 
increase in the volume and weight of the lesions in the KO animals might be associated to the 279 
low elimination rate and high proliferation rate of the endometriotic cells. 280 
 281 
Effect of TNFRp55 deficiency on the factors regulating invasiveness  282 
We analyzed the enzymatic activity of MMP-2 and MMP-9 in homogenates of endometriotic 283 
lesions and peritoneal fluid, and although no significant changes were observed in the lesion 284 
in both experimental groups (Fig. 3A), in peritoneal fluid, the activity of MMP-2 (P<0.001) 285 
and its zymogene increased significantly in the KO animals (P<0.01) (Fig. 3B). These results 286 
suggest that the TNFRp55 deficiency modifies the peritoneal environment, which contributes 287 
to the remodeling and establishment of lesions.  288 
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Effect of the TNFRp55 deficiency on the steroid hormones levels 289 
In the KO animals, the levels of estradiol increased in the peritoneal fluid and in lesion 290 
(P<0.05) (Fig. 4A and B) whereas the expression, analyzed in ectopic uterine tissue, (mRNA 291 
and protein) of P450arom, synthesis enzyme, was not significantly modified (Fig. 4C and D). 292 
These results indicate the close relationship between estradiol and TNFRp55. Pearson’s test 293 
was applied to determine the possible correlation between estradiol levels and MMP-2 294 
activity in peritoneal fluid samples. For the entire group of mice (n=16), positive correlation 295 
was found (coefficient (r) Pearson: 0.67; P<0.01). While, there was no correlation in the wild 296 
type mice (n=8) and deficient mice (n=8) (Fig. 5). 297 
We also analyzed the effect of TNFRp55 deficiency on the progesterone levels in peritoneal 298 
fluid and homogenates of endometriotic lesions, the expression of the metabolic enzymes and 299 
progesterone receptors (PR). In KO animals, the levels of progesterone were not significantly 300 
modified (Fig. 6A and B), whereas the expression (mRNA) of 3β-HSD, synthesis enzyme, 301 
and of 20α-HSD, degradation enzyme, decreased in endometriotic tissue (P<0.01 and 302 
P<0.005, respectively) (Fig. 6C); therefore, the hormone levels were not modified. To 303 
determine if the TNFRp55 deficiency modifies the action sites of progesterone, we analyzed 304 
the expression (mRNA) of the progesterone receptors PR A and PR B, but no changes were 305 
observed (Fig. 6D). 306 
 307 
Discussion 308 
Extensive cell proliferation, tissue remodelling and aberrant apoptosis occur at the ectopic 309 
sites where endometrial tissue deposits develop into endometriotic lesions. In addition, there 310 
is evidence of an aberrant function of the TNF system in this pathology. In the endometrium 311 
of control women, the highest levels of TNF and TNFRp55 are produced during the late 312 
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secretory phase. This phase is related to the apoptosis, which is the physiological process 313 
involved in the menstrual shedding in a non-conceptional cycle. On the contrary, the levels of 314 
TNFRp55 expression in the endometrium of women with endometriosis during the late 315 
secretory phase are lower in relation to the endometrium without endometriosis. This is in 316 
coincidence with the almost absent apoptosis in the eutopic and ectopic endometrium, which 317 
might favor the survival and growth of the menstrual debris outside the uterus (Rojas-318 
Cartagena et al. 2005, Boric et al. 2013). Considering that the abnormal survival of 319 
endometrial cells may result in their continuing growth into ectopic locations and that 320 
TNFRp55 plays a rol in triggering apoptosis, in the present study we selected TNFRp55 as 321 
molecular target and we investigate the effect of TNFRp55 deficiency on the development of 322 
endometriotic-like lesion in a murine model. One of the major limitations of mouse model is 323 
the lack of menstruation and subsequent spontaneous endometriosis. However, this model has 324 
many similarities to the disease in humans, such as the growth of ectopic endometrial tissue 325 
estrogen-dependent. In addition, it is a versatile model that has been used to investigate the 326 
mechanisms involved in the peritoneal attachment of endometrial cells, how the immune 327 
system and hormones affect endometriosis as well as the effects of drugs and therapeutic 328 
products (Grümmer 2006).  329 
The obtained results show that the TNFRp55 deficiency promoted the establishment and the 330 
growth of endometriotic lesions associated to a high rate of cell proliferation and a low rate of 331 
apoptosis. Altogether, these data constitute strong evidence of the association of the 332 
deregulation of the TNFRp55 expression and the survival of the endometriotic tissue in 333 
ectopic sites. 334 
The MMPs have a key role in the pathogenesis of endometriosis. Thus, in a model of induced 335 
endometriosis in mouse, it has been demonstrated that the activity suppression of these 336 
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enzymes leads to inhibition in the endometriosis progression with the subsequent decrease in 337 
the weight of the endometriotic-like lesions (Bruner et al. 1997). In addition, increased levels 338 
of  MMP-2 and MMP-9 have been detected in peritoneal fluid of patients with endometriosis 339 
(Amălinei et al. 2010). In our study, we detected an increase of the enzymatic activity of 340 
MMP-2 in the peritoneal fluid of the KO mice, which indicates that the TNFRp55 deficiency 341 
modifies the peritoneal environment contributing to the lesions remodeling and establishment. 342 
In turn, several studies have shown that the steroid regulation of MMP is critical for the 343 
formation of the fragments of the endometrial tissue in ectopic sites. In relation to this, there 344 
exists a correlation between the levels of MMP-2 and estradiol in the peritoneal fluid of 345 
patients with endometriosis (Huang et al. 2004). In agreement with this, we also observed the 346 
presence of high levels of estradiol that correlate with an increase in MMP-2 activity, which 347 
might favor the establishment and development of endometriotic lesions. It is important to 348 
emphasize that the TNFRp55-/- mice lack expression of TNFRp55 but display normal 349 
numbers of high affinity TNFRp75 molecules (Pfeffer et al. 1993). In surgically induced 350 
endometriosis in rat and mouse, the treatment with etanercept, a fusion protein consisting of 351 
human recombinant soluble TNFRp75 conjugated to a human Fc antibody subunit, was 352 
associated with negative immunohistochemical staining for TNFRp75 and with reduced 353 
endometriosis development (Islimye et al. 2011, Liu et al. 2016). These data indicate that the 354 
lack of activity of the TNFRp75, a receptor associated mainly with proliferation, cell survival 355 
and angiogenesis (Haider et al. 2009, Cabal-Hierro & Lazo 2012) suppresses the development 356 
of endometriosis and that the effects observed in TNFRp55 deficient animals of the present 357 
study may be due to activation of TNFRp75 dependent pathways.  358 
Specifically in relation to the steroid hormones and endometriosis, estradiol is a factor 359 
favoring its development while the role of progesterone seems to be attenuating. The 360 
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TNFRp55 deficiency did not modify either the levels of progesterone or its action sites. On 361 
the other hand, we observed that the TNFRp55 deficiency caused a strong effect on the 362 
estradiol levels, which suggests the close relationship between estradiol and TNFRp55. It is 363 
well known that endometriotic lesions have the capacity to produce estradiol since they 364 
express the complete set of steroidogenic enzymes (Kianpour et al. 2015). Among these 365 
enzymes, P450arom plays an important role in endometriosis (Bulun et al. 2000, Bilotas et al. 366 
2010). However, in our experimental model, this enzyme was not modified by the TNFRp55 367 
deficiency. It is also important to take into account that the beginning and development of this 368 
disorder might be promoted not only by the estrogen synthesized at local level but also by the 369 
systemic estrogen (Rizner 2009). Thus, the estradiol from the ovary and from the conversion 370 
of androstenedione circulating in the adipose tissue and skin reaches the lesion via circulation. 371 
Therefore, the previous mechanism might explain the increase observed in the estradiol level 372 
in peritoneal fluid and endometriotic lesion.  373 
There is strong evidence of the bidirectional communication between the endocrine and 374 
immune system. For example, it has been described that estrogens may contribute to tumor 375 
development, blocking the ability of immune cells to induce apoptosis of target cancer cells 376 
(Jiang et al. 2008). In endometriosis, the high level of estradiol can also play an important 377 
role in a local decrease of immunosurveillance (Vetvicka et al. 2016). In addition, in vitro 378 
studies suggest that endometriotic cells respond to estrogen-induced antiapoptotic signaling 379 
more intensely than normal cells (Reis et al. 2013). We postulate that hormones, especially 380 
estradiol, may regulate the expression of the gene that codifies TNFRp55 and that this might 381 
be a mechanism involved in the survival of the endometriotic cells in ectopic sites. In support 382 
of this hypothesis, we have mapped 1800 bp upstream from the initial site of the TNFRp55 383 
gene transcription using MatInspector software (Quandt et al. 1995), and we identified four 384 
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putative oestrogen response element and one putative progesterone response elements (results 385 
not shown). In addition, a study through hybridization in situ demonstrated that the uterus of 386 
adult mice expresses mRNA of TNFRp55 and after the ovariectomy and 72 h of estradiol 387 
administration, the mRNA that codifies TNFRp55 in uterine cells decreased (Roby et al. 388 
1996). These date indicate that estradiol may modulate the expression of the gene encoding 389 
TNFRp55. Whether this mechanism is involved in the decreased susceptibility of 390 
endometriotic cells to apoptosis associated to estradiol remains to be investigated. 391 
In conclusion, the deficiency of TNFRp55 promoted the establishment and development of 392 
endometriosis through an increase in the lesion size and high levels of estradiol which 393 
correlate with an increase in the MMP-2 activity. Further studies on the deregulation of the 394 
TNFRp55 expression and the survival of the endometrial cells in ectopic sites might 395 
contribute to improve the knowledge about pathophysiology and to discover possible 396 
therapies or biomarkers of endometriosis.   397 
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Figure legends 
Figure 1. Establishment and growth of endometriotic lesions. The number of established 
endometriotic lesions (A), the volume (B), the weight (C) and were assessed in mice wild type 
(WT) n=12 y TNFRp55-/- (KO) n=11 after 4 week of induced endometriosis. Statistical 
comparisons were performed by Student “t” test. * P<0.05, ■ P<0.001. 
 
Figure 2. Cell proliferation and apoptosis in endometriotic lesions. (A) The percentage of 
proliferating cells was assessed by immunohistochemistry for PCNA in endometriotic lesions. 
Micrographs show representative histological sections of endometriotic lesions of WT (n=11) 
(i) and KO (n=7) (ii). As a negative control, one section of each slide was assayed without the 
primary antibody (iii). Statistical comparisons were performed by Student “t” test. •P<0.01. 
(B) The percentage of apoptosis cells was assessed by TUNEL in endometriotic lesions. 
Micrographs show representative histological sections of endometriotic lesions of WT (n=8) 
(iv) and KO (n=8) (v). As a negative control, one section of each slide was assayed without 
the primary antibody (vi). Statistical comparisons were performed by Student “t” test. ■ 
P<0.001. 
 
Figure 3. Enzyme activities of MMP-2 and MMP-9. MMP-2 and MMP-9 (proenzyme and 
active forms) enzymatic activity was determined by SDS-PAGE gelatin zymography in 
endometriotic lesions (A) and peritoneal fluid (B). The gel photographs were quantified using 
ImageJ and expressed as in relative units. Results are expressed as mean ± S.E.M of eight 
animals per experimental group. Student’s t-test was used. • P<0.01, ■ P<0.001. 
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Figure 4. Estradiol levels and P450aromatase expression. Estradiol levels were measured by 
RIA in peritoneal fluid (A) and endometriotic lesions (B). Measurement by RT-PCR of 
expression (mRNA) of P450arom and β-actin as housekeeping gene (C). Measurement by 
Western Blot of expression (protein) of P450arom and β-actin as load control (D). The gel 
photographs were quantified using ImageJ and expressed as in relative units. Results are 
expressed as mean ± S.E.M of eight animals per experimental group. Student’s t-test was 
used. *P<0.05. 
 
Figure 5. Pearson’s correlation between estradiol levels and MMP-2 activity in peritoneal 
fluid samples. For the entire group of mice (n=16), coefficient (r) Pearson: 0.67. 
 
 Figure 6. Progesterone levels, expression of metabolic enzymes and progesterone receptors. 
Progesterone levels were measured by RIA in peritoneal fluid (A) and endometriotic lesions 
(B) Measurement by RT-PCR of expression (mRNA) of 3β-HSD, 20α-HSD (C), PR (D). β-
actin was used as housekeeping gene. The gel photographs were quantified using ImageJ and 
expressed as in relative units. Results are expressed as mean ± S.E.M of eight animals per 
experimental group. Student’s t-test was used. • P<0.01, ♦P<0.005. 
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Table 1.  Primer used for semi-quantitative RT-PCR amplification. 
Gen Sequences  





N° of cycles 
3β-HSD GTCTTCAGACCAGAAACCAAG 
CCTTAAGGCACAAGTATGCAG 





NM_134066 141 35 





PR-B GGTCCCCCTTGCTTGCA                                   
CAGGACCGAGGAAAAAGCAG 




















Establishment and growth of endometriotic lesions. The number of established endometriotic lesions (A), the 
volume (B), the weight (C) and were assessed in mice wild type (WT) n=12 y TNFRp55-/- (KO) n=11 after 4 
week of induced endometriosis. Statistical comparisons were performed by Student “t” test. * P<0.05, ■ 
P<0.001.  
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assessed by immunohistochemistry for PCNA in endometriotic lesions. Micrographs show representative 
histological sections of endometriotic lesions of WT (n=11) (i) and KO (n=7) (ii). As a negative control, one 
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by Student “t” test. •P<0.01. (B) The percentage of apoptosis cells was assessed by TUNEL in endometriotic 
lesions. Micrographs show representative histological sections of endometriotic lesions of WT (n=8) (iv) and 
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Progesterone levels, expression of metabolic enzymes and progesterone receptors. Progesterone levels were 
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